<sup>18</sup>F-FDG PET/CT显像与结直肠癌治疗前分期的相关性研究

田蓉蓉; 薄云峰; 张毅勋; 原凌; 赵铭; 张红雨; 田蓉蓉; 薄云峰; 张毅勋; 原凌; 赵铭; 张红雨

doi:10.3760/cma.j.issn.1673-4114.2018.01.002

[1]

Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):E359-E386. DOI:10.1002/ijc.29210.

[2]

Maffione AM, Lopci E, Bluemel C, et al. Diagnostic accuracy and impact on management of ¹⁸F-FDG PET and PET/CT in colorectal liver metastasis:a meta-analysis and systematic review[J]. Eur J Nucl Med Mol Imaging, 2015, 42(1):152-163. DOI:10.1007/s00259-014-2930-4.

[3]

O'Sullivan B, Brierley J, Byrd D, et al. The TNM classification of malignant tumours-towards common understanding and reasonable expectations[J]. Lancet Oncol, 2017, 18(7):849-851. DOI:10.1016/S1470-2045(17)30438-2.

[4]

Lee JY, Yoon SM, Kim JT, et al. Diagnostic and prognostic value of preoperative ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for colorectal cancer:comparison with conventional computed tomography[J]. Intest Res, 2017, 15(2):208-214. DOI:10.5217/ir.2017.15.2.208.

[5]

Altini C, Niccoli Asabella A, De Luca R, et al. Comparison of ¹⁸F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer[J]. Abdom Imaging, 2015, 40(5):1190-1202. DOI:10.1007/s00261-014-0277-8.

[6]

Jo HJ, Kim SJ, Kim IJ, et al. Predictive value of volumetric parameters measured by ¹⁸F-FDG PET/CT for lymph node status in patients with surgically resected rectal cancer[J]. Ann Nucl Med, 2014, 28(3):196-202. DOI:10.1007/s12149-014-0809-x.

[7]

Uchiyama S, Haruyama Y, Asada T, et al. Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers[J]. Surg Today, 2012, 42(10):956-961. DOI:10.1007/s00595-012-0225-6.

[8]

王晓燕, 彭桂娟, 张祥松, 等.基于¹⁸氟-脱氧葡萄糖正电子发射计算机断层成像术的最大标准化摄取值和放射线基线比值与结直肠癌术后预后的关系[J].中华胃肠外科杂志, 2015, 18(3):232-237. DOI:10.3760/cma.j.issn.1671-0274.2015.03.008.
Wang XY, Peng GJ, Zhang XS, et al. Correlation of ¹⁸F-FDG PET-CT maximum standard uptake value and T/N ratio with the prognosis of postoperative colorectal cancer[J]. Chin J Gastrointest Surg, 2015, 18(3):232-237. doi: 10.3760/cma.j.issn.1671-0274.2015.03.008

[9]

吴珊, 刘长存, 宋建华, 等. ¹⁸F-FDG PET/CT在结肠癌术前TNM分期中的价值及SUV_max与患者临床特征的相关性研究[J].肿瘤影像学, 2017, 26(1):35-42. DOI:10.3969/j.issn.1008-617X.2017. 01.007.
Wu S, Liu CC, Song JH, et al. Clinical value of ¹⁸F-FDG PET/CT in preoperative TNM staging and SUV_max in patients with colon cancer[J]. Oncoradiol, 2017, 26(1):35-42. doi: 10.3969/j.issn.1008-617X.2017.01.007

[10]

陈虞梅, 刘建军, 陈涛, 等. PET诊断结直肠癌复发价值及误诊原因的Meta分析[J].中华核医学杂志, 2007, 27(3):131-134. DOI:10.3760/cma.j.issn.2095-2848.2007.03.002.
Chen YM, Liu JJ, Chen T, et al. Meta-analysis on the diagnostic value of PET in recurrent colorectal cancer and on factors inducing misdiagnosis[J]. Chin J Nucl Med, 2007, 27(3):131-134. doi: 10.3760/cma.j.issn.2095-2848.2007.03.002

[11]

Tang-Christensen M, Vrang N, Larsen PJ. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment[J]. Diabetes, 1998, 47(4):530-537. DOI:10.2337/diabetes.47.4.530.

[12]

丁重阳, 李天女, 孙晋. ¹⁸F-FDG PET/CT代谢参数与结直肠癌临床病理特征的关系[J].临床肿瘤学杂志, 2017, 22(1):53-57. DOI:10.3969/j.issn.1009/0460.2017.01.011.
Ding CY, Li TN, Sun J. The relationship between ¹⁸F-FDG PET/CT metabolic parameters and clinicopathological factors of colorectal Cancer[J]. Chin Clin Oncol, 2017, 22(1):53-57. doi: 10.3969/j.issn.1009/0460.2017.01.011

[13]

胡俊杰, 周志祥, 梁建伟, 等.左、右半结肠癌患者临床病理特点及预后差异分析[J].中华医学杂志, 2015, 95(28):2268-2271. DOI:10.3760/cma.j.issn.0376-2491.2015.28.006.
Hu JJ, Zhou ZX, Liang JW, et al. Analysis of clinicopathologic and survival characteristics in patients with right-or left-sided colon cancer[J]. Natl Med J China, 2015, 95(28):2268-2271. doi: 10.3760/cma.j.issn.0376-2491.2015.28.006

[14]

Kekelidze M, D'Errico L, Pansini M, et al. Colorectal cancer:current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation[J]. World J Gastroenterol, 2013, 19(46):8502-8514. DOI:10.3748/wjg.v19.i46.8502.

[15]

Kendi AT, Corey A, Magliocca KR, et al. Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration?[J]. Eur J Radiol, 2016, 85(2):319-323. DOI:10.1016/j.ejrad.2015.11.039.

[16]

Chang S, Koo PJ, Kwak JJ, et al. Changes in total lesion glycolysis evaluated by repeated ¹⁸F FDG PET/CT as prognostic factor in locally advanced esophageal cancer patients treated with preoperative chemoradiotherapy[J]. Oncology, 2016, 90(2):97-102. DOI:10.1159/000443018.

[17]

Chen S, Ibrahim NK, Yan Y, et al. Risk stratification in patients with advanced-stage breast cancer by pretreatment ¹⁸F-FDG PET/CT [J]. Cancer, 2015, 121(22): 3965-3974. DOI: 10.1002/cncr.29565.